Skip to content

Adia Med, Inc.

ADIA · OTCM

CIK 1160420fmd_1MWJ58SNY9V427PBY18QD73DM4Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Jan 01, 2024 to Jun 30, 2026, 6 periods

Latest annual · FY2025

Millions
Total revenues
1
Gross profit
0
Operating income
(0)
Net income
(0)
Free cash flow
(0)

Latest quarter · Q2 FY2026

Millions
Total revenues
0
Gross profit
0
Operating income
0
Net income
0
Free cash flow
(0)
Open Financials

Adia Med, Inc. (ADIA) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$700,508$6,380+10,879.7%10-K 2026-03-31 · proof
Gross profit$191,670$2,194+8,636.1%10-K 2026-03-31 · proof
Operating income-$366,492-$174,74910-K 2026-03-31 · proof
Net income-$395,464-$181,06710-K 2026-03-31 · proof
Cash from operating activities-$179,228-$335,47610-K 2026-03-31 · proof
Free cash flow-$192,428-$357,30710-K 2026-03-31 · proof
Total assets$594,826$666,181-10.7%10-K 2026-03-31 · proof
Total liabilities$852,500$640,641+33.1%10-K 2026-03-31 · proof
Cash and cash equivalents$79,392$6,323+1,155.6%10-K 2026-03-31 · proof
What was Adia Med, Inc. (ADIA)'s revenue in fiscal 2025?
Adia Med, Inc. (ADIA) reported revenue of $700,508 for fiscal 2025 (the year ended Dec 31, 2025), against $6,380 the year before (+10,879.7%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What was Adia Med, Inc. (ADIA)'s gross profit in fiscal 2025?
Adia Med, Inc. (ADIA) reported gross profit of $191,670 for fiscal 2025 (the year ended Dec 31, 2025), against $2,194 the year before (+8,636.1%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What was Adia Med, Inc. (ADIA)'s operating income in fiscal 2025?
Adia Med, Inc. (ADIA) reported operating income of -$366,492 for fiscal 2025 (the year ended Dec 31, 2025), against -$174,749 the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What was Adia Med, Inc. (ADIA)'s net income in fiscal 2025?
Adia Med, Inc. (ADIA) reported net income of -$395,464 for fiscal 2025 (the year ended Dec 31, 2025), against -$181,067 the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What was Adia Med, Inc. (ADIA)'s cash from operating activities in fiscal 2025?
Adia Med, Inc. (ADIA) reported cash from operating activities of -$179,228 for fiscal 2025 (the year ended Dec 31, 2025), against -$335,476 the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What was Adia Med, Inc. (ADIA)'s free cash flow in fiscal 2025?
Adia Med, Inc. (ADIA) reported free cash flow of -$192,428 for fiscal 2025 (the year ended Dec 31, 2025), against -$357,307 the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What are Adia Med, Inc. (ADIA)'s total assets?
As of Dec 31, 2025, Adia Med, Inc. (ADIA) reported total assets of $594,826, against $666,181 a year earlier (-10.7%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What are Adia Med, Inc. (ADIA)'s total liabilities?
As of Dec 31, 2025, Adia Med, Inc. (ADIA) reported total liabilities of $852,500, against $640,641 a year earlier (+33.1%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What are Adia Med, Inc. (ADIA)'s cash and cash equivalents?
As of Dec 31, 2025, Adia Med, Inc. (ADIA) reported cash and cash equivalents of $79,392, against $6,323 a year earlier (+1,155.6%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:ADIA&period_type=annual&limit=5"

Information only, not investment advice.